57
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Abnormal Rheology in Cyanotic Congenital Heart Disease - A Factor in Non-immune Nephropathy

Pages 411-415 | Published online: 09 Jul 2009

References

  • Akita H, Matsuoka S, Kuroda Y. Nephropathy in patients with cyanotic congenital heart disease. Tokushima J Exp Med 1993; 40: 47–53.
  • Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol 2000; 86: 1198–204.
  • Burlet A, Drukker A, Guignard JP. Renal function in cyanotic congenital heart disease. Nephron 1999; 81: 296–300.
  • Dittrich S, Haas NA, Buehrer C, Mueller C, Daehnert I, Lange PE. Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr 1998; 87: 949–54.
  • Krull F, Ehrich JH, Wurster U, Toel U, Rothganger S, Luhmer I. Renal involvement in patients with congenital cyanotic heart disease. Acta Paediatr Scand 1991; 80: 1214–19.
  • Bauer W, Rosenberg B. A quantitative study of glomerular enlargement in children with tetralogy of Fallot. Am J Pathol 1960; 37: 695–712.
  • Spear GS. The glomerular lesion of cyanotic congenital heart disease. Johns Hopkins Med J 1977; 140: 185–8.
  • Spear G. The glomerulus in cyanotic congenital heart disease and primary pulmonary hypertension. Nephron 1964; 1: 238–48.
  • Dintenfass L. Internal viscosity of the red cell and a blood viscosity equation. Nature 1968; 219: 956–8.
  • Messmer K, Sunder-Plassmann L. Hemodilution. Prog Surg 1974; 13: 208–45.
  • Dintenfass L. Haemorheology of diabetes mellitus. Adv Microcirc 1979; 8: 14–36.
  • Begg TB, Heams JB. Components in blood viscosity. The relative contribution of haematocrit, plasma fibrino-gen and other proteins. Clin Sci 1966; 31: 87–93.
  • Sumpio BE, Upchurch GR, Johnson G Jr. The influence of perfusate viscosity, RBC deformability and drag on the function of an isolated perfused rat kidney. J Surg Res 1989; 46: 4–8.
  • Kontras SB, Bodenbender JG, Craenen J, Hosier DM. Hyperviscosity in congenital heart disease. J Pediatr 1970; 76: 214–20.
  • Linderkamp 0, Klose HJ, Betke K, Brodherr-Heberlein S, Buhlmeyer K, Kelson S, et al. Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. J Pediatr 1979; 95: 567–9.
  • Spear GS, Kihara I. The glomerulus and serum sickness in experimental hypoxia. Br J Exp Pathol 1972; 53: 265–76.
  • Roofe PG, Garrett GF. Renal changes associated with acclimatization to high altitude. Anat Rec 1965; 153: 311–15.
  • Wilcox CS, Deng X, Doll AH, Snellen H, Welch WJ. Nitric oxide mediates renal vasodilation during erythro-poietin-induced polycythemia. Kidney Int 1993; 44: 430–5.
  • Raij L, Shultz PJ. Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus. J Am Soc Nephrol 1993; 3: 1435–41.
  • Imig JD, Roman RJ. Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 1992; 19: 770–4.
  • Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derange-ments, renal function, and urate metabolism. Cardiol Clin 1993; 11: 689–99.
  • Territo MC, Rosove MH. Cyanotic congenital heart disease: hematologic management. J Am Coll Cardiol 1991; 18: 320–2.
  • Mair DD. Effect of markedly elevated hematocrit level on blood viscosity and assessment of pulmonary vascular resistance. J Thorac Cardiovasc Surg 1979; 77: 682–4.
  • Agarwal JB, Paltoo R, Palmer WH. Relative viscosity of blood at varying hematocrits in pulmonary circulation. J Appl Physiol 1970; 29: 866–71.
  • Roos A. Poiseuille' s law and its limitations in vascular systems. Med Thoracalis 1962; 19: 224–38.
  • Simpson LO, Shand BI, Olds RJ. A reappraisal of the influence of blood rheology on glomerular filtration and its role in the pathogenesis of diabetic nephropathy. J Diabet Complications 1987; 1: 137–44.
  • Garcia DL, Anderson S, Rennke HG, Brenner BM. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA 1988; 85: 6142–6.
  • Wilcox CS, Payne J, Harrison BD. Renal function in patients with chronic hypoxaemia and cor pulmonale following reversal of polycythaemia. Nephron 1982; 30: 173–7.
  • de Jong PE, Weening JJ, Donker AJ, van der Hem GK. The effect of phlebotomy on renal function and proteinuria in a patient with congenital cyanotic heart disease. Nephron 1983; 33: 225–6.
  • Muirhead N, Cattran DC, Zaltzman J, Jindal K, First MR, Boucher A, et al. Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction. J Am Soc Nephrol 1994; 5: 1216–22.
  • Dittrich S, Kurschat K, Daehnert I, Vogel M, Mueller C, Alexi-Meskishvili V, et al. Renal function after cardio-pulmonary bypass surgery in cyanotic congenital heart disease. Int J Cardiol 2000; 73: 173–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.